Harmen Beurmanjer

113 References Rolland, B., Labreuche, J., Duhamel, A., Deheul, S., Gautier, S., Auffret, M., … Cottencin, O. (2015). Baclofen for alcohol dependence: Relationships between baclofen and alcohol dosing and the occurrence of major sedation. European Neuropsychopharmacology , 25 (10), 1631–1636. https://doi.org/10.1016/j.euroneuro.2015.05.008 Ros-Cucurull, E., Palma-álvarez, R. F., García-Raboso, E., Cardona-Rubira, C., Jacas, C., Grau-López, L., … Roncero, C. (2018). Benzodiazepine use disorder and cognitive impairment in older patients: A six-month-follow-up study in an outpatient unit in Barcelona. Journal of Studies on Alcohol and Drugs . https://doi.org/10.15288/ jsad.2018.79.844 Rosenberg, M. H., Deerfield, L. J., & Baruch, E. M. (2003). Two Cases of Severe Gamma-Hydroxybutyrate Withdrawal Delirium on a Psychiatric Unit: Recommendations for Management. The American Journal of Drug and Alcohol Abuse , 29 (2), 487–496. https://doi.org/10.1081/ADA-120020529 Schellekens, A. F. A., de Jong, C. A. J., Buitelaar, J. K., & Verkes, R. J. (2015). Co-morbid anxiety disorders predict early relapse after inpatient alcohol treatment. European Psychiatry , 30 (1), 128–136. https://doi.org/10.1016/j. eurpsy.2013.08.006 Schep, L. J., Knudsen, K., Slaughter, R. J., Vale, J. A., & Mégarbane, B. (2012). The clinical toxicology of gamma-hydroxy- butyrate, gamma-butyrolactone and 1,4-butanediol. Clinical Toxicology , 50 (6), 458–470. https://doi.org/10.310 9/15563650.2012.702218 Schippers, G. M., Broekman, T. G., Buchholz, A., Koeter, M. W. J., & Van Den Brink, W. (2010). Measurements in the Addictions for Triage and Evaluation (MATE): An instrument based on the World Health Organization family of international classifications. Addiction , 105 (5), 862–871. https://doi.org/10.1111/j.1360-0443.2009.02889.x Schmitz, J. M., Green, C. E., Hasan, K. M., Vincent, J., Suchting, R., Weaver, M. F., … Lane, S. D. (2017). PPAR-gamma agonist pioglitazone modifies craving intensity and brain white matter integrity in patients with primary cocaine use disorder: a double-blind randomized controlled pilot trial. Addiction , 112 (10), 1861–1868. https:// doi.org/10.1111/add.13868 Schuurmans, M. J., Shortridge-Baggett, L. M., & Duursma, S. A. (2003). The Delirium Observation Screening Scale: A Screening Instrument for Delirium. ResearchandTheory for NursingPractice , 17 (1), 31–50. https://doi.org/10.1891/ rtnp.17.1.31.53169 Sinha, R., & Jastreboff, A. M. (2013). Stress as a common risk factor for obesity and addiction. Biological Psychiatry . https://doi.org/10.1016/j.biopsych.2013.01.032 Sivilotti, M. L. A., Burns, M. J., Aaron, C. K., & Greenberg, M. J. (2001). Pentobarbital for severe gamma-butyrolactone withdrawal. Annals of Emergency Medicine , 38 (6), 660–665. https://doi.org/10.1067/mem.2001.119454 Snead 3rd, O. C., & Gibson, K. M. (2005). Gamma-hydroxybutyric acid. New England Journal of Medicine , 352 (26), 2721–2732. Snead, O. C. 3rd, & Morley, B. J. (1981). Ontogeny of gamma-hydroxybutyric acid. I. Regional concentration in developing rat, monkey and human brain. Brain Research , 227 (4), 579–589. Snead, O. C., & Gibson, K. M. (2005). γ-Hydroxybutyric Acid. New England Journal of Medicine , 352 , 2721–2732. Strand, N. A. W., Petersen, T. S., Nielsen, L. M., & Boegevig, S. (2017). Treatment of gamma-hydroxybutyrate withdrawal. Ugeskrift for Laeger , Vol. 179. Strauss, A., & Corbin, J. (1994). Grounded theory methodology. Handbook of Qualitative Research , pp. 273–285. https:// doi.org/10.1007/BF00988593 Sumnall, H. R., Woolfall, K., Edwards, S., Cole, J. C., & Beynon, C. M. (2008). Use, function, and subjective experiences of gamma-hydroxybutyrate (GHB). Drug and Alcohol Dependence , 92 (1–3), 286–290. https://doi.org/10.1016/j. drugalcdep.2007.07.009 Tarabar, A. F., & Nelson, L. S. (2004). The gamma-hydroxybutyrate withdrawal syndrome. Toxicological Reviews , 23 (1), 45–49. Terrier, J., Ort, A., Yvon, C., Saj, A., Vuilleumier, P., & Lüscher, C. (2011). Bi-directional effect of increasing doses of baclofen on reinforcement learning. Frontiers in Behavioral Neuroscience , 5 (July), 40. https://doi.org/10.3389/ fnbeh.2011.00040 Theodore, P. S., Durán, R. E., & Antoni, M. H. (2014). Drug Use and Sexual Risk Among Gay and Bisexual Men Who Frequent Party Venues. AIDS and Behavior , 18 (11), 2178–2186. https://doi.org/10.1007/s10461-014-0779-y Turner, T. H., LaRowe, S., Horner, M. D., Herron, J., &Malcolm, R. (2009). Measures of cognitive functioning as predictors of treatment outcome for cocaine dependence. Journal of Substance Abuse Treatment , 37 (4), 328–334. https:// doi.org/10.1016/j.jsat.2009.03.009